76 results on '"Edwards, I. Ralph"'
Search Results
2. Comment on “Safety of Human Papillomavirus Vaccines: An Updated Review”
3. Evaluation of Facebook and Twitter Monitoring to Detect Safety Signals for Medical Products: An Analysis of Recent FDA Safety Alerts
4. Patient-Reported Safety Information: A Renaissance of Pharmacovigilance?
5. Current Safety Concerns with Human Papillomavirus Vaccine: A Cluster Analysis of Reports in VigiBase®
6. Pharmacovigilance is … Vigilance
7. Quantitative benefit-risk assessment of methylprednisolone in multiple sclerosis relapses
8. The ISoP CommSIG for Improving Medicinal Product Risk Communication: A New Special Interest Group of the International Society of Pharmacovigilance
9. Teaching Pharmacovigilance: the WHO-ISoP Core Elements of a Comprehensive Modular Curriculum
10. Adverse Drug Effects and Their Clinical Management: A Personal View
11. Computing limits on medicine risks based on collections of individual case reports
12. Pharmacovigilance for Children’s Sake
13. Methylprednisolone-induced hepatotoxicity: experiences from global adverse drug reaction surveillance
14. Patient-Reported Outcome Measures in Safety Event Reporting: PROSPER Consortium Guidance
15. The Development and Evaluation of Triage Algorithms for Early Discovery of Adverse Drug Interactions
16. Attitudes among healthcare professionals to the reporting of adverse drug reactions in Nepal
17. Communicating the New Pharmacovigilance Landscape
18. Remembering Dr Jerry Labadie 1957–2012
19. Remembering Dr Jerry Labadie 1957–2012
20. Decision Dilemmas
21. Good Pharmacovigilance Practice and the Curateʼs Egg
22. Clinical Diagnosis
23. Prevention and Pharmacovigilance
24. Patient Follow-Up and Monitoring Medicines
25. Off-Label Pharmacovigilance
26. Communication in Drug Safety
27. The Authorʼs Reply
28. Conflicts of Interest in Medicines Safety and Regulation
29. Fraudulent and Substandard Medicines
30. Suspected Adverse Drug Reactions Reported For Children Worldwide
31. Dose Variations Associated with Formulations of NSAID Prescriptions for Children
32. Social Media and Networks in Pharmacovigilance
33. Reporting Patterns Indicative of Adverse Drug Interactions
34. Pharmacovigilance and the Null Hypothesis
35. African Heat
36. Earlier discovery of pregabalin’s dependence potential might have been possible
37. Reflections on Attribution and Decisions in Pharmacovigilance
38. What do Stakeholders Think about Pharmacovigilance?
39. Placebo Harm
40. First, Catch Your Signal!
41. Wonder Vigilance
42. Tomorrowʼs World
43. Temporal pattern discovery in longitudinal electronic patient records
44. A Risk Worth Taking?
45. Outliers and Patients with Adverse Drug Reactions
46. Understanding and Communicating Key Concepts in Risk Management
47. Risk Management of Medicines and Compensation for Harm
48. The Good Old Drugs!
49. The ISoP Bengt-Erik Wiholm Memorial Lecture
50. The future of pharmacovigilance: a personal view
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.